<h3>Gainers</h3>
<ul>
<li>PACS Group (NYSE:PACS) shares increased by 15.4% to $36.8 during Monday's after-market session. The company's market cap stands at $5.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>BioVie (NASDAQ:BIVI) shares moved upwards by 7.4% to $1.45. The company's market cap stands at $11.0 million. </li>
<li>GT Biopharma (NASDAQ:GTBP) shares increased by 7.29% to $0.37. The market value of their outstanding shares is at $13.3 million. </li>
<li>AbCellera Biologics (NASDAQ:ABCL) shares increased by 7.04% to $5.62. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q1 earnings came out today. </li>
<li>P3 Health Partners (NASDAQ:PIII) stock increased by 6.4% to $4.02. The market value of their outstanding shares is at $11.6 million. </li>
<li>Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 5.78% to $5.3. The company's market cap stands at $10.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WORK Medical Tech Gr (NASDAQ:WOK) shares decreased by 27.6% to $2.84 during Monday's after-market session. </li>
<li>Ensysce Biosciences (NASDAQ:ENSC) stock fell 14.04% to $0.33. The market value of their outstanding shares is at $3.2 million. </li>
<li>aTyr Pharma (NASDAQ:ATYR) shares decreased by 12.65% to $0.83. The market value of their outstanding shares is at $92.7 million. </li>
<li>CEL-SCI (AMEX:CVM) stock fell 12.3% to $1.24. The market value of their outstanding shares is at $14.3 million. </li>
<li>Harrow (NASDAQ:HROW) shares declined by 10.81% to $33.93. The company's market cap stands at $1.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Odysight ai (NASDAQ:ODYS) stock declined by 10.53% to $4.25. The market value of their outstanding shares is at $74.7 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PACS

ABCL

In Monday's after-market session, PACS Group shares surged 15.4% to $36.8 following its Q1 earnings report, with a market cap of $5.2 billion. Other gainers included BioVie (+7.4%), GT Biopharma (+7.29%), and AbCellera Biologics (+7.04%). Conversely, WORK Medical Tech saw the largest decline at -27.6%, followed by Ensysce Biosciences (-14.04%) and aTyr Pharma (-12.65%).

benzinga_article

WORK Medical Tech

Abcellera Biologics

ATYR Pharma

Ensysce Biosciences

Biovie

GT Biopharma

iShares US Medical Devices

SPDR S&P Health Equip

Health Care Select Sector SPDR

iShares US Healthcare Providers

ALPS Medical Breakthrough

iShares Biotechnology ETF

iShares Global Healthcare

SPDR S&P Health

iShares US Pharma

VG Health

P3 Health Partners

Advanced Biomed

CEL-SCI

Harrow

Odysight.ai

BIOVIE INC C/WTS 08/08/2030(TO PUR COM)

P3 HEALTH PARTNERS INC C/WTS 19/11/2026 (TO PUR COM)

Ensysce Biosciences - CW22

Harrow Health Pref Share HROWM 11.875 12/31/27

Harrow Health Pref Share HROWL 8.625 04/30/26

12 Health Care Stocks Moving In Monday's After-Market Session